Injection liquid anti-seepage device for local sealing of skin

By designing a skin local closure injection anti-exudation device with a closure pad, adhesive layer and absorption device, the problem of liquid exudation is solved, efficient absorption and convenient operation are achieved, and the treatment effect and patient comfort are improved.

CN223350444UActive Publication Date: 2025-09-19AFFILIATED HOSPITAL OF HEBEI UNIV OF ENG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202422268348.0
Authority / Receiving Office
CN · China
Patent Type
Utility models(China)
Current Assignee / Owner
Filing Date
2024-09-18
Publication Date
2025-09-19
Estimated Expiration
2034-09-18

AI Technical Summary

Technical Problem

Existing technologies are difficult to effectively solve the problem of liquid leakage during local skin block injection. Traditional methods have limited absorption capacity and poor fixation effect, increase the risk of infection and are inconvenient to operate, affecting the treatment effect and patient comfort.

Method used

An anti-exudation device is designed, which includes a closing pad, an adhesive layer, a tearing device and an absorption device. The closing pad is provided with a cavity filled with a hydrocolloid dressing block and a mesh. The mesh blocks the exudate and the hydrocolloid dressing block absorbs it. The tearing device is easy to operate and ensures the stability of the adhesion.

Benefits of technology

It effectively prevents fluid leakage, reduces the risk of infection, improves treatment effects and patient comfort, simplifies operating procedures, reduces the difficulty of medical staff's work, and improves treatment compliance.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN223350444U_ABST
    Figure CN223350444U_ABST
Patent Text Reader

Abstract

The utility model relates to the technical field of medical treatment, in particular to an anti-leakage device for local closed injection liquid of skin, which comprises a closed pad, a cavity is arranged in the middle of the right end of the closed pad, a sticking layer is fixedly connected around the right end of the closed pad, a tearing device is adhered to the right end of the sticking layer, and the tearing device is connected with a sealing pad. The cavity is filled with an absorption device, and a net body is fixedly connected to the middle of the right end of the sealing pad. The absorption device comprises a hydrocolloid dressing block, the outer surface of the hydrocolloid dressing block is fixedly connected with an elastic layer, and the cavity is filled with the hydrocolloid dressing block. According to the liquid seepage prevention device for the local closed injection of the skin, the tearing device and the absorption device are arranged, so that liquid seepage during local closed injection of the skin can be effectively prevented, the infection risk is reduced, a stable and reliable environment is provided for various types of injection treatment, and the treatment effect is guaranteed.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The utility model relates to the technical field of medical treatment, in particular to a device for preventing leakage of injected liquid for local skin sealing. Background Art

[0002] In the medical field, local skin block injection is a common treatment method, widely used in the treatment of various diseases, such as pain management, control of local inflammation, etc. However, when performing local skin block injection, the problem of liquid exudation often brings troubles to treatment. Traditional treatment methods are often relatively simple, such as using ordinary gauze or bandages for covering, but these methods have many shortcomings. The absorption capacity of gauze is limited, which easily leads to the accumulation of exudate at the injection site, increasing the risk of infection. The bandage has poor fixation effect and is easy to shift, and cannot effectively prevent liquid exudation. In addition, some existing anti-exudation measures may cause greater irritation to the patient's skin, causing discomfort or even allergic reactions. Moreover, these methods are often not convenient in operation, which increases the difficulty and time cost of medical staff. Therefore, we introduce a new anti-exudation device for local skin block injection of liquid. Utility Model Content

[0003] The main purpose of the utility model is to provide a device for preventing leakage of injected liquid for local skin closure, which can effectively solve the problems in the background technology.

[0004] In order to achieve the above purpose, the technical solution adopted by the utility model is:

[0005] A device for locally sealing the skin to prevent the leakage of injected liquid, comprising a sealing pad, a cavity being formed in the middle of the right end of the sealing pad, an adhesive layer being fixedly connected around the right end of the sealing pad, a tearing device being bonded to the right end of the adhesive layer, an absorbent device being filled in the cavity, and a mesh being fixedly connected to the middle of the right end of the sealing pad;

[0006] The absorption device comprises a hydrocolloid dressing block, an outer surface of which is fixedly connected with an elastic layer, and the hydrocolloid dressing block is filled in the cavity.

[0007] Preferably, the tearing device includes a release layer, a transparent layer is fixedly connected to the middle of the right end of the release layer, a tear strip is fixedly connected to the lower front end of the release layer, and the release layer is bonded to the right end of the adhesive layer.

[0008] By adopting the above technical solution, the transparent layer makes it easy to observe the condition of the adhesive layer before use to check whether there is contamination or damage.

[0009] Preferably, the hydrocolloid dressing block is located on the left side of the mesh body.

[0010] By adopting the above technical solution, it is ensured that the exudate is first initially blocked and dispersed by the mesh body and then absorbed by the hydrocolloid dressing block, thereby improving the absorption efficiency and effect.

[0011] Preferably, the release layer and the adhesive layer are in a detachable adhesive structure.

[0012] By adopting the above technical solution, the release layer can be easily torn off during use to expose the adhesive layer for the adhesive operation.

[0013] Preferably, the size of the release layer is the same as that of the adhesive layer.

[0014] By adopting the above technical solution, the adhesive layer can be fully protected, the adhesiveness of the adhesive layer is not affected by the outside world, and the firmness and stability of the adhesive are guaranteed.

[0015] Preferably, the sealing pad and the hydrocolloid dressing piece are an integral structure.

[0016] By adopting the above technical solution, the hydrocolloid dressing block is prevented from shifting or falling off during use, thereby ensuring the anti-exudation effect.

[0017] Compared with the prior art, the present invention has the following beneficial effects:

[0018] 1. In the present invention, by providing an absorption device, the efficient absorption of the hydrocolloid dressing block, the adaptive fit of the elastic layer, the barrier and dispersion of the mesh body, and the convenient operation of the tearing device can effectively prevent the leakage of liquid during local skin occlusion injection. This not only reduces the risk of infection, but also provides a stable and reliable environment for various types of injection treatments, ensuring the treatment effect. When injecting irritating drugs, it avoids the irritation and damage of the drugs to the surrounding skin. When it is necessary to keep the local skin dry for a long time, it maintains the good condition of the local skin and promotes wound recovery.

[0019] 2. In the present invention, the design of the tearing device fully considers the convenience and comfort of the user. The tearing device makes the preparation work simple and quick, saving time. The hydrocolloid dressing block and the elastic layer reduce the patient's discomfort. The synergistic effect of the overall structure reduces the operation difficulty of medical staff and improves work efficiency. At the same time, its good anti-exudation effect enhances the patient's treatment experience and increases treatment compliance. BRIEF DESCRIPTION OF THE DRAWINGS

[0020] Figure 1 This is a schematic diagram of the overall structure of a device for preventing leakage of liquid injected into the skin for local closure of the present invention;

[0021] Figure 2 This is a schematic structural diagram of an absorption device for a device for preventing leakage of injected liquid in a local skin closure according to the present invention;

[0022] Figure 3 This is a schematic structural diagram of a tearing device for preventing leakage of injected liquid in a local skin closure according to the present invention;

[0023] Figure 4 This is a schematic diagram of the enlarged structure of the details of point A of the device for preventing leakage of liquid injected into the skin for local closure of the skin according to the present invention.

[0024] In the figure: 1. Sealing pad; 2. Tear device; 3. Absorbent device; 4. Adhesive layer; 5. Cavity; 6. Mesh; 31. Elastic layer; 32. Hydrocolloid dressing block; 21. Release layer; 22. Tear strip; 23. Transparent layer. DETAILED DESCRIPTION

[0025] In order to make the technical means, creative features, objectives and effects achieved by the present invention easier to understand, the present invention is further described below in conjunction with specific implementation methods.

[0026] In the description of this utility model, it should be noted that the terms "upper," "lower," "inner," "outer," "front end," "rear end," "both ends," "one end," "the other end," and the like, indicating orientations or positional relationships, are based on the orientations or positional relationships shown in the accompanying drawings and are intended solely to facilitate the description of this utility model and simplify the description. They are not intended to indicate or imply that the devices or components referred to must have a specific orientation, be constructed, or operate in a specific orientation. Therefore, they should not be construed as limitations on this utility model. Furthermore, the terms "first" and "second" are used for descriptive purposes only and should not be construed as indicating or implying relative importance.

[0027] In the description of this utility model, it should be noted that, unless otherwise expressly specified or limited, the terms "installed," "provided with," "connected," etc. should be understood in a broad sense. For example, "connected" can mean a fixed connection, a detachable connection, or an integral connection; it can be a mechanical connection or an electrical connection; it can be a direct connection or an indirect connection through an intermediate medium, or it can be internal communication between two components. Those skilled in the art will be able to understand the specific meanings of the above terms in this utility model based on the specific circumstances.

[0028] See also Figure 1-4 , the utility model provides a technical solution:

[0029] A device for locally sealing the skin to prevent the leakage of injected liquids, comprising a sealing pad 1, a cavity 5 being defined in the middle of the right end of the sealing pad 1, an adhesive layer 4 being fixedly connected to the periphery of the right end of the sealing pad 1, a tearing device 2 being bonded to the right end of the adhesive layer 4, an absorbent device 3 being filled in the cavity 5, and a mesh 6 being fixedly connected to the middle of the right end of the sealing pad 1;

[0030] The sealing pad 1 and the hydrocolloid dressing piece 32 are integrally formed.

[0031] In this embodiment, the absorption device 3 includes a hydrocolloid dressing block 32 , the outer surface of which is fixedly connected to the elastic layer 31 , and the hydrocolloid dressing block 32 fills the cavity 5 ; the hydrocolloid dressing block 32 is located on the left side of the mesh 6 .

[0032] Through the above scheme: after a local closed injection of the skin, if there is liquid exudation, the hydrocolloid dressing block 32 located on the left side of the mesh body 6 will quickly absorb the exudate due to its good water absorption, and the elastic layer 31 on the outer surface of the hydrocolloid dressing block 32 can make the dressing block better fit the shape of the cavity 5, fully contact with the exudate, and improve the absorption efficiency. The hydrocolloid dressing block 32 can quickly and effectively absorb the exudate and keep the injection site dry. In some injection operations with frequent exudate, it can continue to play a good absorption role. The elastic layer 31 enables the absorption device 3 to adapt to cavities 5 of different shapes and sizes, ensuring that the absorption effect is not affected by the difference in the shape of the device, absorbing the exudate in time, avoiding long-term contact of the liquid with the skin, and reducing irritation and damage to the skin.

[0033] In this embodiment, the tearing device 2 includes a release layer 21, a transparent layer 23 is fixedly connected to the middle of the right end of the release layer 21, a tear strip 22 is fixedly connected to the lower front end of the release layer 21, and the release layer 21 is bonded to the right end of the adhesive layer 4; the release layer 21 and the adhesive layer 4 are in a detachable adhesive structure; the size of the release layer 21 is the same as the size of the adhesive layer 4.

[0034] Through the above solution: by grasping the tear strip 22 at the lower front end of the release layer 21, the release layer 21 is torn off from the adhesive layer 4, thereby exposing the adhesive layer 4, making it convenient to stick the closure pad 1 to the injection site of the skin. The design of the tear strip 22 makes the operation of removing the release layer 21 simple and quick, saving preparation time. The transparent layer 23 in the middle of the right end of the release layer 21 allows the user to observe the condition of the adhesive layer 4 before removing the release layer 21 to ensure that it is not damaged or contaminated. The release layer 21 is the same size as the adhesive layer 4, which can fully and evenly protect the viscosity of the adhesive layer 4 and improve the stability and reliability of the adhesion.

[0035] It should be noted that the present invention is a device for preventing liquid exudation from being injected into the skin for local closure. During use, first, before performing local closure injection of the skin, the release layer 21 is torn off from the adhesive layer 4 by the tearing strip 22 of the tearing device 2. Then, the closure pad 1 is pasted on the skin of the injection site through the adhesive layer 4 to make it fit tightly. During the injection process, when liquid exudates, the mesh 6 can play a certain blocking and dispersing role to prevent the exudate from directly spreading over a large area. The hydrocolloid dressing block 32 in the absorption device 3 located in the cavity 5 can quickly absorb the exudate due to its own characteristics. The elastic layer 31 on the outer surface of the hydrocolloid dressing block 32 It can provide a certain degree of elasticity and cushioning, which helps to better adapt to the morphology of the skin surface and enhance the absorption effect. When the injected drug is a certain irritant and liquid seeps out, the device can absorb it in time to avoid the drug from irritating and damaging the surrounding skin. When the injection site needs to be kept dry for a long time, this device can continuously absorb the exudate and maintain the dry state of the local skin, which is beneficial to the recovery of the wound and the protection of the treatment effect. In general, this anti-exudation device effectively prevents the leakage of liquid during local skin closure injection through the synergistic effect of adhesive fixation, mesh 6 blocking, and hydrocolloid dressing block 32 absorption, providing better protection for treatment.

[0036] The above shows and describes the basic principles, main features and advantages of the present invention. Those skilled in the art should understand that the present invention is not limited to the above embodiments. The above embodiments and descriptions are merely illustrative of the principles of the present invention. Various changes and improvements may be made to the present invention without departing from the spirit and scope of the present invention. Such changes and improvements are intended to fall within the scope of the present invention. The scope of protection claimed in this invention is defined by the appended claims and their equivalents.

Claims

1. A device for preventing leakage of injected liquid for local skin closure, comprising a closure pad (1), characterized in that: A cavity (5) is formed in the middle of the right end of the sealing pad (1); an adhesive layer (4) is fixedly connected to the periphery of the right end of the sealing pad (1); a tearing device (2) is bonded to the right end of the adhesive layer (4); an absorbing device (3) is filled in the cavity (5); and a mesh body (6) is fixedly connected to the middle of the right end of the sealing pad (1); The absorption device (3) comprises a hydrocolloid dressing block (32), the outer surface of the hydrocolloid dressing block (32) is fixedly connected to an elastic layer (31), and the hydrocolloid dressing block (32) is filled in the cavity (5).

2. The device for preventing leakage of injection liquid for local skin sealing according to claim 1, characterized in that: The tearing device (2) comprises a release layer (21), a transparent layer (23) is fixedly connected to the middle of the right end of the release layer (21), a tear strip (22) is fixedly connected to the lower front end of the release layer (21), and the release layer (21) is bonded to the right end of the adhesive layer (4).

3. The device for preventing leakage of injection liquid for local skin sealing according to claim 1, characterized in that: The hydrocolloid dressing block (32) is located on the left side of the mesh body (6).

4. The device for preventing leakage of injection liquid for local skin sealing according to claim 2, characterized in that: The release layer (21) and the adhesive layer (4) are in a detachable adhesive structure.

5. The device for preventing leakage of injection liquid for local skin sealing according to claim 2, characterized in that: The size of the release layer (21) is the same as the size of the adhesive layer (4).

6. The device for preventing leakage of injection liquid for local skin sealing according to claim 1, characterized in that: The sealing pad (1) and the hydrocolloid dressing block (32) are an integrated structure.